Notice ID: 53be4defb53c488e9a2ee724a13a328bPresolicitation
Q--RBC Health as a Novel Biomarker of a Successful Outcome in Hematopoietic Stem C
Archived on December 3, 2022. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 5:00 PM UTC−05:00
- Posted
- October 27, 2022
- Notice type
- Presolicitation
- NAICS
- 621511: Medical Laboratories
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NHLBI
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- 75N92023Q0540
- Notice ID
- 53be4defb53c488e9a2ee724a13a328b
Description
RBC Health as a Novel Biomarker of a Successful Outcome in Hematopoietic Stem Cell Transplantation (HSCT) for Sickle Cell Disease (SCD)
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75N92023Q0540- Pre-Solicitation
Formal solicitation typically follows within 30–60 days. (estimate)
- Pre-SolicitationCurrentOct 27, 2022
Q--RBC Health as a Novel Biomarker of a Successful Outcome in Hematopoietic Stem C
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N92023Q0540
Archive Date
Dec 3, 2022
Office Address
BETHESDA, MD, 20892